Abpro Holdings, Inc. (ABPO) stock
ABPOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ABPWW
$0.41+0.00 (+0.11%)
Close on Oct 19, 2026Market cap $2.41MP/E –Yield –
Abpro operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Abpro's operating income for the twelve months ending Jun 30, 2026 was -$5.34M. For fiscal 2025 it was -$8.45M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$8.45M | – |
| FY2024 | Dec 31, 2024 | -$9.92M | – |
| FY2023 | Dec 31, 2023 | -$11.75M | – |
| FY2022 | Dec 31, 2022 | -$2.05M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.18M | – |
| Q1 FY2026 | Mar 31, 2026 | -$933.00K | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.90M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.34M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.26M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.96M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.34M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.88M | – |
| Q4 FY2023 | Dec 31, 2023 | -$10.47M | – |
| Q3 FY2023 | Sep 30, 2023 | -$315.25K | – |
| Q2 FY2023 | Jun 30, 2023 | -$420.34K | – |
| Q1 FY2023 | Mar 31, 2023 | -$537.56K | – |
| Q4 FY2022 | Dec 31, 2022 | -$588.65K | – |
| Q3 FY2022 | Sep 30, 2022 | -$533.80K | – |
| Q2 FY2022 | Jun 30, 2022 | -$434.43K | – |
| Q1 FY2022 | Mar 31, 2022 | -$493.54K | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.00K | – |
See a number that looks wrong?